Imagine a medical brain-scan that is usually huge and expensive, now shrunk down into a portable cap and a smartphone app. A non-expert can put the cap on a patient, and the app acts like a digital coach to ensure the recording is perfect. The data then flies through the cloud to a doctor far away who can diagnose the patient from another country.
Millions of people in low-income regions cannot be treated for epilepsy because they lack access to expensive EEG machines and trained neurologists.
A CE-marked portable EEG device (BC-1), an AI-guided Android app for non-experts, and a secure cloud-based telemedicine platform.
If you are a distributor dealing with the lack of expensive neurology equipment in rural clinics — this project developed the BC-1 device that provides hospital-grade EEG recordings at a low cost. It allows you to sell a complete diagnostic service rather than just hardware.
If you are a platform provider dealing with the difficulty of capturing clean medical data remotely — this project developed an AI-guided smartphone app that ensures non-experts capture usable EEG scans. This removes the need for on-site specialists during data collection.
If you are a health agency dealing with 40M people suffering from untreated epilepsy in LMICs — this project developed a CE-marked, portable EEG system. It closes the treatment gap by bringing diagnosis to the point of care without requiring on-site neurologists.
Based on available project data, the system is designed as a low CAPEX, affordable diagnostic service utilizing low-cost hardware and existing mobile phone infrastructure.
Yes, the project focused on LMICs and has already deployed units across a wide range of clinical environments to validate usability and durability for broader scale-up.
The project mentions a proprietary smartphone application and a CE-marked device (BC-1), though specific licensing terms are not detailed in the report.
Yes, the BC-1 hardware is CE-marked and has passed all necessary verification, validation, and regulatory documentation steps.
Data is captured via an Android app, sent to a secure cloud platform, and read by remote experts who then provide a diagnosis and treatment plan back through the app.
The project is led by a single SME, BrainCapture APS from Denmark, which handled 100% of the industry implementation. This lean structure allowed the company to move rapidly from hardware development to CE certification and field testing without the complexity of a large multi-partner consortium.
Contact BrainCapture APS in Denmark for commercial inquiries regarding the BC-1 system.
Contact us to explore partnership opportunities with BrainCapture for LMIC market entry.
